Ishita Drugs and Industries Limited (BOM:524400)

Market Cap	230.25M +1.4%
Revenue (ttm)	161.68M +8.3%
Net Income	8.89M +3.1%
EPS	2.97 +3.1%
Shares Out	2.99M
PE Ratio	25.93
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	108
Average Volume	962
Open	76.01
Previous Close	76.06
Day's Range	76.01 - 77.00
52-Week Range	66.00 - 90.85
Beta	-0.46
RSI	50.20
Earnings Date	May 26, 2026

About BOM:524400

Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. Ishita Drugs and Industries Limited was incorporated in 1992 and is based in A...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1992
• Employees: 14
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524400

Financial Performance

In fiscal year 2025, BOM:524400's revenue was 149.97 million, a decrease of -1.25% compared to the previous year's 151.88 million. Earnings were 8.68 million, an increase of 15.98%.